Exploring genetic testing requests, genetic alterations and clinical associations in a cohort of children with autism spectrum disorder.

[1]  J. Martinez-Agosto,et al.  Ethical challenges in autism genomics: Recommendations for researchers. , 2023, European journal of medical genetics.

[2]  B. Crespo-Facorro,et al.  miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis , 2023, European child & adolescent psychiatry.

[3]  B. King,et al.  Autism Spectrum Disorder: A Review. , 2023, JAMA.

[4]  Judith Eberhardt,et al.  A systematic review and meta-analysis on the prevalence of mental disorders among children and adolescents in Europe , 2022, European child & adolescent psychiatry.

[5]  Sokindra Kumar,et al.  A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers, Pharmacological and Non-Pharmacological Interventions. , 2022, CNS & neurological disorders drug targets.

[6]  American Psychiatric Association.  Diagnostic and Statistical Manual of Mental Disorders , 2022 .

[7]  A. Kolevzon,et al.  Comorbidities in autism spectrum disorder and their etiologies , 2022, Translational Psychiatry.

[8]  E. Fombonne,et al.  Global prevalence of autism: A systematic review update , 2022, Autism research : official journal of the International Society for Autism Research.

[9]  K. Tammimies,et al.  Access, utilization, and awareness for clinical genetic testing in autism spectrum disorder in Sweden: A survey study , 2021, Autism : the international journal of research and practice.

[10]  Alejandro Segura-Tudela,et al.  Towards a Change in the Diagnostic Algorithm of Autism Spectrum Disorders: Evidence Supporting Whole Exome Sequencing as a First-Tier Test , 2021, Genes.

[11]  J. Hebebrand,et al.  Need for psychiatric phenotyping in patients with rare genetic disorders , 2021, European Child & Adolescent Psychiatry.

[12]  A. Gerard,et al.  Outcomes of prior authorization requests for genetic testing in outpatient pediatric genetics clinics , 2021, Genetics in Medicine.

[13]  Christopher G Chute,et al.  The Human Phenotype Ontology in 2021 , 2020, Nucleic Acids Res..

[14]  W. Barbaresi,et al.  Pathogenic Yield of Genetic Testing in Autism Spectrum Disorder , 2020, Pediatrics.

[15]  I. Dinstein,et al.  Factors Affecting Family Compliance with Genetic Testing of Children Diagnosed with Autism Spectrum Disorder , 2020, Journal of Autism and Developmental Disorders.

[16]  C. Phornphutkul,et al.  Clinical Genetic Testing in Autism Spectrum Disorder in a Large Community-Based Population Sample , 2020, JAMA psychiatry.

[17]  Beth A. Smith,et al.  Quantitative Gait Analysis in Duplication 15q Syndrome and Nonsyndromic ASD , 2020, Autism research : official journal of the International Society for Autism Research.

[18]  R. Boles,et al.  State of the Art of Genetic Testing for Patients With Autism: A Practical Guide for Clinicians. , 2020, Seminars in pediatric neurology.

[19]  E. Bacchelli,et al.  An integrated analysis of rare CNV and exome variation in Autism Spectrum Disorder using the Infinium PsychArray , 2020, Scientific Reports.

[20]  S. Levy,et al.  Identification, Evaluation, and Management of Children With Autism Spectrum Disorder , 2019, Pediatrics.

[21]  Sunil Q. Mehta,et al.  Association of Comorbid Mood and Anxiety Disorders With Autism Spectrum Disorder. , 2019, JAMA pediatrics.

[22]  Sean K. Simmons,et al.  In vivo Perturb-Seq reveals neuronal and glial abnormalities associated with autism risk genes , 2019, Science.

[23]  T. Dudding-Byth,et al.  Significantly Elevated FMR1 mRNA and Mosaicism for Methylated Premutation and Full Mutation Alleles in Two Brothers with Autism Features Referred for Fragile X Testing , 2019, International journal of molecular sciences.

[24]  A. Tobías,et al.  Temporal and Geographical Variability of Prevalence and Incidence of Autism Spectrum Disorder Diagnoses in Children in Catalonia, Spain , 2019, Autism research : official journal of the International Society for Autism Research.

[25]  S. Scherer,et al.  Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders , 2019, Genetics in Medicine.

[26]  Matthew W. Mosconi,et al.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism , 2019, Cell.

[27]  L. Biesecker,et al.  The ACMG/AMP reputable source criteria for the interpretation of sequence variants , 2018, Genetics in Medicine.

[28]  S. Schwartz,et al.  Yield of Additional Genetic Testing after Chromosomal Microarray for Diagnosis of Neurodevelopmental Disability and Congenital Anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) , 2018, Genetics in Medicine.

[29]  J. Canals,et al.  Prevalence and Characteristics of Autism Spectrum Disorder Among Spanish School-Age Children , 2018, Journal of Autism and Developmental Disorders.

[30]  Stormy J. Chamberlain,et al.  Genetic testing including targeted gene panel in a diverse clinical population of children with autism spectrum disorder: Findings and implications , 2017, Molecular genetics & genomic medicine.

[31]  Sven Sandin,et al.  The Heritability of Autism Spectrum Disorder , 2017, JAMA.

[32]  L. Pérez-Jurado,et al.  Provision of Genetic Services for Autism and its Impact on Spanish Families , 2017, Journal of Autism and Developmental Disorders.

[33]  Maxime W. C. Rousseaux,et al.  Disruption of the ATXN1–CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans , 2017, Nature Genetics.

[34]  E. Wassman,et al.  Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders , 2016, BioMed research international.

[35]  Rita M Cantor,et al.  Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex Families. , 2016, American journal of human genetics.

[36]  Peter Szolovits,et al.  Genetic Misdiagnoses and the Potential for Health Disparities. , 2016, The New England journal of medicine.

[37]  S. Bölte,et al.  Quo Vadis clinical genomics of ASD? , 2016, Autism : the international journal of research and practice.

[38]  Á. Carracedo,et al.  Comprehensive molecular testing in patients with high functioning autism spectrum disorder. , 2016, Mutation research.

[39]  P. Bolton,et al.  Heritability of autism spectrum disorders: a meta‐analysis of twin studies , 2015, Journal of child psychology and psychiatry, and allied disciplines.

[40]  Ricardo Villamarín-Salomón,et al.  ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..

[41]  John Wei,et al.  Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder. , 2015, JAMA.

[42]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[43]  François Schiettecatte,et al.  OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..

[44]  M. Cuccaro,et al.  Genetic testing and corresponding services among individuals with autism spectrum disorder (ASD) , 2014, American journal of medical genetics. Part A.

[45]  Stephan J Sanders,et al.  Modest Impact on Risk for Autism Spectrum Disorder of Rare Copy Number Variants at 15q11.2, Specifically Breakpoints 1 to 2 , 2014, Autism research : official journal of the International Society for Autism Research.

[46]  D. Cohen,et al.  Are There Cultural Differences in Parental Interest in Early Diagnosis and Genetic Risk Assessment for Autism Spectrum Disorder? , 2014, Front. Pediatr..

[47]  Sharmila Banerjee-Basu,et al.  SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs) , 2013, Molecular Autism.

[48]  G. B. Schaefer,et al.  Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions , 2013, Genetics in Medicine.

[49]  A. Hardan,et al.  Parental Interest in a Genetic Risk Assessment Test for Autism Spectrum Disorders , 2013, Clinical pediatrics.

[50]  Bradley P. Coe,et al.  Estimates of penetrance for recurrent pathogenic copy-number variations , 2012, Genetics in Medicine.

[51]  L. Feuk,et al.  Diagnostic interpretation of array data using public databases and internet sources , 2012, Human mutation.

[52]  K. Kok,et al.  Practical guidelines for interpreting copy number gains detected by high-resolution array in routine diagnostics , 2011, European Journal of Human Genetics.

[53]  S. South,et al.  American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants , 2011, Genetics in Medicine.

[54]  L. Hudgins,et al.  Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities , 2010, Genetics in Medicine.

[55]  Leslie G Biesecker,et al.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.

[56]  Sharyn A. Lincoln,et al.  Clinical Genetic Testing for Patients With Autism Spectrum Disorders , 2010, Pediatrics.

[57]  P. Sahota,et al.  Essential versus complex autism: Definition of fundamental prognostic subtypes , 2005, American journal of medical genetics. Part A.

[58]  G. Delong.  Autism , 1999, Neurology.

[59]  IN RURAL AREAS , 1983 .